Compare · MDLN vs STSS
MDLN vs STSS
Side-by-side comparison of Medline Inc. (MDLN) and Sharps Technology Inc. (STSS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both MDLN and STSS operate in Medical/Dental Instruments (Health Care), so they compete in similar markets.
- MDLN is the larger of the two at $45.60B, about 585.5x STSS ($77.9M).
- Over the past year, MDLN is down 14.9% and STSS is down 65.1% - MDLN leads by 50.2 points.
- MDLN has been more active in the news (18 items in the past 4 weeks vs 2 for STSS).
- MDLN has more recent analyst coverage (25 ratings vs 0 for STSS).
PerformanceMDLN-14.90%STSS-34.64%
2025-12-17+0.00%2026-06-22
- Company
- Medline Inc.
- Sharps Technology Inc.
- Price
- $34.68-3.43%
- $1.84+1.10%
- Market cap
- $45.60B
- $77.9M
- 1M return
- -4.30%
- +2.22%
- 1Y return
- -14.90%
- -65.09%
- Industry
- Medical/Dental Instruments
- Medical/Dental Instruments
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2025
- 2022
- News (4w)
- 18
- 2
- Recent ratings
- 25
- 0
STSS
Sharps Technology Inc.
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Latest MDLN
- Officer Abrams William J covered exercise/tax liability with 1,308 shares, decreasing direct ownership by 7% to 16,546 units (SEC Form 4)
- Chief Human Resources Officer Shryock Christopher P covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Operating Officer Miller Stephen L covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Legal Officer Liberman Alexander M. covered exercise/tax liability with 872 shares, decreasing direct ownership by 7% to 11,031 units (SEC Form 4)
- Chief Product Officer Laabs Amanda H. covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Financial Officer Drazin Michael B covered exercise/tax liability with 1,889 shares, decreasing direct ownership by 7% to 23,899 units (SEC Form 4)
- Chief Commercial Officer Golwas Douglas P covered exercise/tax liability with 1,889 shares, converted options into 100,000 shares, sold $3,677,115 worth of shares (100,000 units at $36.77) as part of a pre-agreed trading plan and returned 100,000 units of Class B Common Stock to the company, increasing direct ownership by 1,319% to 365,864 units (SEC Form 4)
- Chief Executive Officer Boyle James M covered exercise/tax liability with 2,370 shares, decreasing direct ownership by 7% to 29,369 units (SEC Form 4)
- Director Galanti Richard A was granted 16,392 shares (SEC Form 4)
- Director Sweet Thomas W was granted 17,800 shares (SEC Form 4)
Latest STSS
- SEC Form 3 filed by new insider Levine Arthur
- Sharps Technology Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits
- Sharps Technology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits
- SkyAI Appoints Veteran Finance Executive Arthur Levine as Chief Financial Officer
- Sharps Technology Becomes SkyAI, Inc. with New Ticker Symbol "SKYA"; Establishing Category-defining Agentic Finance Platform Serving Global South
- Amendment: SEC Form SCHEDULE 13G/A filed by Sharps Technology Inc.
- Sharps Technology Reports Continued Growth in Q1 2026 Highlighting Strengthened Balance Sheet and Strong Treasury Execution
- Sharps Technology Adopts Limited Duration Stockholder Rights Plan
- SEC Form 10-Q filed by Sharps Technology Inc.
- Sharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury Strategy